ClinicalTrials.govpublic full text
Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults
human metapneumovirus and human parainfluenza infection, mrna-1653, human metapneumovirus, human parainfluenza vaccine, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847716
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.